Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Abrocitinib Tablets

Approval Number

国药准字HJ20220031

CompanyPFIZER INC.

Registration Date

April 8, 2022

Drug Information

Generic Name

阿布昔替尼片

Trade Name

希必可

Dosage Form

片剂

Strength

200mg

Drug Type

化学药品

Registration Date

April 8, 2022

Expiry Date

April 7, 2027

Company Information

Applicant Company

Company NamePFIZER INC.

Company Address

66 Hudson Boulevard East, New York, NY 10001 United States of America

Manufacturing Company

Company NamePfizer Manufacturing Deutschland GmbH

Company Address

Betriebsstatte Freiburg Mooswaldallee 1 79090 Freiburg, Germany

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

阿布昔替尼片 - NMPA 批准文号 | MedPath